175 related articles for article (PubMed ID: 31949330)
1. Antioxidative enzyme activity and total antioxidant capacity in serum of dogs with degenerative mitral valve disease.
Michałek M; Tabiś A; Cepiel A; Noszczyk-Nowak A
Can J Vet Res; 2020 Jan; 84(1):67-73. PubMed ID: 31949330
[TBL] [Abstract][Full Text] [Related]
2. A pilot study investigating circulating trimethylamine N-oxide and its precursors in dogs with degenerative mitral valve disease with or without congestive heart failure.
Karlin ET; Rush JE; Freeman LM
J Vet Intern Med; 2019 Jan; 33(1):46-53. PubMed ID: 30511765
[TBL] [Abstract][Full Text] [Related]
3. Serum serotonin concentrations in dogs with degenerative mitral valve disease.
Arndt JW; Reynolds CA; Singletary GE; Connolly JM; Levy RJ; Oyama MA
J Vet Intern Med; 2009; 23(6):1208-13. PubMed ID: 19709352
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Vein-to-Pulmonary Artery Ratio is an Echocardiographic Index of Congestive Heart Failure in Dogs with Degenerative Mitral Valve Disease.
Merveille AC; Bolen G; Krafft E; Roels E; Gomart S; Etienne AL; Clercx C; Mc Entee K
J Vet Intern Med; 2015; 29(6):1502-9. PubMed ID: 26415640
[TBL] [Abstract][Full Text] [Related]
5. Pathologic Manifestations on Surgical Biopsy and Their Correlation with Clinical Indices in Dogs with Degenerative Mitral Valve Disease.
Lee J; Mizuno M; Mizuno T; Harada K; Uechi M
J Vet Intern Med; 2015; 29(5):1313-21. PubMed ID: 26214756
[TBL] [Abstract][Full Text] [Related]
6. Auscultatory, echocardiographic, biochemical, nutritional, and environmental characteristics of mitral valve disease in Norfolk terriers.
Trafny DJ; Freeman LM; Bulmer BJ; MacGregor JM; Rush JE; Meurs KM; Oyama MA
J Vet Cardiol; 2012 Mar; 14(1):261-7. PubMed ID: 22364691
[TBL] [Abstract][Full Text] [Related]
7. Prediction of first onset of congestive heart failure in dogs with degenerative mitral valve disease: the PREDICT cohort study.
Reynolds CA; Brown DC; Rush JE; Fox PR; Nguyenba TP; Lehmkuhl LB; Gordon SG; Kellihan HB; Stepien RL; Lefbom BK; Meier CK; Oyama MA
J Vet Cardiol; 2012 Mar; 14(1):193-202. PubMed ID: 22366568
[TBL] [Abstract][Full Text] [Related]
8. Association between atrial fibrillation and right-sided manifestations of congestive heart failure in dogs with degenerative mitral valve disease or dilated cardiomyopathy.
Ward J; Ware W; Viall A
J Vet Cardiol; 2019 Feb; 21():18-27. PubMed ID: 30797441
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism, coupling interval and prematurity index in dogs with degenerative mitral valve disease and ventricular arrhythmias.
Carvalho ER; Ampuero RAN; Tuleski GLR; Camacho AA; Sousa MG
Vet Res Commun; 2018 Jun; 42(2):153-160. PubMed ID: 29536334
[TBL] [Abstract][Full Text] [Related]
10. The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease.
Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Souttar K; Elliott J
J Vet Intern Med; 2012; 26(2):302-11. PubMed ID: 22369312
[TBL] [Abstract][Full Text] [Related]
11. Effect of a specially formulated diet on progression of heart enlargement in dogs with subclinical degenerative mitral valve disease.
Oyama MA; Scansen BA; Boswood A; Goldfeder G; Rosenthal S; Cober R; LaFauci K; Friese RC; Gomes M; Chang YR; Li Q
J Vet Intern Med; 2023; 37(4):1323-1330. PubMed ID: 37392086
[TBL] [Abstract][Full Text] [Related]
12. Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease.
Oyama MA; Chittur SV
Am J Vet Res; 2006 Aug; 67(8):1307-18. PubMed ID: 16881841
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal electrocardiographic evaluation of dogs with degenerative mitral valve disease.
López-Alvarez J; Boswood A; Moonarmart W; Hezzell MJ; Lotter N; Elliott J
J Vet Intern Med; 2014; 28(2):393-400. PubMed ID: 24494591
[TBL] [Abstract][Full Text] [Related]
14. Phosphoproteomics analysis of serum from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
Sakarin S; Rungsipipat A; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Charoenlappanit S; Thaisakun S; Surachetpong S
PeerJ; 2024; 12():e17186. PubMed ID: 38708342
[TBL] [Abstract][Full Text] [Related]
15. Histopathological changes of pulmonary vascular remodeling in dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
Sakarin S; Rungsipipat A; Surachetpong SD
J Vet Cardiol; 2021 Aug; 36():141-152. PubMed ID: 34284267
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of and risk factors for degenerative mitral valve disease in dogs attending primary-care veterinary practices in England.
Mattin MJ; Boswood A; Church DB; López-Alvarez J; McGreevy PD; O'Neill DG; Thomson PC; Brodbelt DC
J Vet Intern Med; 2015; 29(3):847-54. PubMed ID: 25857638
[TBL] [Abstract][Full Text] [Related]
17. New insights into degenerative mitral valve disease in dogs.
Häggström J; Duelund Pedersen H; Kvart C
Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1209-26, vii-viii. PubMed ID: 15325478
[TBL] [Abstract][Full Text] [Related]
18. Correlation between activation of the sympathetic nervous system estimated by plasma concentrations of norepinephrine and Doppler echocardiographic variables in dogs with acquired heart disease.
Marcondes Santos M; Strunz CM; Larsson MH
Am J Vet Res; 2006 Jul; 67(7):1163-8. PubMed ID: 16817737
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in the serotonin transporter protein gene in Maltese dogs with degenerative mitral valve disease.
Lee CM; Han JI; Kang MH; Kim SG; Park HM
J Vet Sci; 2018 Jan; 19(1):129-135. PubMed ID: 28693307
[TBL] [Abstract][Full Text] [Related]
20. Canine degenerative myxomatous mitral valve disease: natural history, clinical presentation and therapy.
Borgarelli M; Haggstrom J
Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):651-63. PubMed ID: 20610017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
